Detailed information for compound 1592934

Basic information

Technical information
  • TDR Targets ID: 1592934
  • Name: N-cycloheptyl-1-(4-methoxyphenyl)sulfonylpipe ridine-4-carboxamide
  • MW: 394.528 | Formula: C20H30N2O4S
  • H donors: 1 H acceptors: 3 LogP: 3.16 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)S(=O)(=O)N1CCC(CC1)C(=O)NC1CCCCCC1
  • InChi: 1S/C20H30N2O4S/c1-26-18-8-10-19(11-9-18)27(24,25)22-14-12-16(13-15-22)20(23)21-17-6-4-2-3-5-7-17/h8-11,16-17H,2-7,12-15H2,1H3,(H,21,23)
  • InChiKey: DHDQFBUYSMEDFJ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-cycloheptyl-1-(4-methoxyphenyl)sulfonyl-piperidine-4-carboxamide
  • N-cycloheptyl-1-(4-methoxyphenyl)sulfonyl-4-piperidinecarboxamide
  • N-cycloheptyl-1-(4-methoxyphenyl)sulfonyl-isonipecotamide
  • ZINC00783871
  • 1-(4-Methoxy-benzenesulfonyl)-piperidine-4-carboxylic acid cycloheptylamide
  • BAS 04831383

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens epoxide hydrolase 2, cytoplasmic Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Mycobacterium ulcerans epoxide hydrolase EphA Get druggable targets OG5_129061 All targets in OG5_129061
Mycobacterium tuberculosis Probable epoxide hydrolase EphA (epoxide hydratase) (arene-oxide hydratase) Get druggable targets OG5_129061 All targets in OG5_129061

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Mycobacterium ulcerans carbonic anhydrase 0.1022 0.3634 0.3634
Trichomonas vaginalis conserved hypothetical protein 0.2466 1 0.5
Echinococcus multilocularis carbonic anhydrase II 0.0303 0.0464 0.5
Entamoeba histolytica carbonic anhydrase, putative 0.1022 0.3634 0.5
Mycobacterium leprae CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) 0.1022 0.3634 1
Onchocerca volvulus 0.0413 0.0951 0.5
Mycobacterium tuberculosis Beta-carbonic anhydrase CanB 0.0523 0.1437 0.1841
Trypanosoma cruzi carbonic anhydrase-like protein, putative 0.0303 0.0464 0.5
Mycobacterium tuberculosis Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) 0.0975 0.343 0.4396
Trypanosoma cruzi carbonic anhydrase-like protein, putative 0.0303 0.0464 0.5
Brugia malayi Putative carbonic anhydrase 5 precursor 0.0303 0.0464 0.5
Brugia malayi Eukaryotic-type carbonic anhydrase family protein 0.0303 0.0464 0.5
Schistosoma mansoni carbonic anhydrase 0.1022 0.3634 1
Leishmania major carbonic anhydrase family protein, putative 0.1022 0.3634 1
Loa Loa (eye worm) carbonic anhydrase 3 0.0303 0.0464 0.5
Mycobacterium tuberculosis Probable conserved transmembrane protein 0.0477 0.1233 0.158
Echinococcus granulosus carbonic anhydrase II 0.0303 0.0464 0.5
Trichomonas vaginalis conserved hypothetical protein 0.2466 1 0.5
Onchocerca volvulus Putative sulfate transporter 0.0413 0.0951 0.5
Mycobacterium tuberculosis Beta-carbonic anhydrase 0.1967 0.7803 1
Loa Loa (eye worm) eukaryotic-type carbonic anhydrase 0.0303 0.0464 0.5
Trypanosoma brucei carbonic anhydrase-like protein 0.0303 0.0464 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 450 nM Inhibition of human soluble epoxide hydrolase using CMNPC as substrate after 5 mins by fluorescent assay ChEMBL. 22079754

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.